Drug
Lemborexant clinical trials
Also written E2006 and Dayvigo.
- studies test it
- 51
- open now
- 16
- in phase 3
- 7
- first study started
- 2011
Keep track of what changes. Save the lemborexant studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
51 studies that test it; most in 2024 (6)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 22
- Phase 2
- 17
- Phase 3
- 7
- Phase 4
- 8
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 26
Eisai Inc. (22) · Eisai Co., Ltd. (3) · University of California, San Francisco (2) · Chulalongkorn University (2) · Virginia Commonwealth University (2) · Baylor College of Medicine (1) · Indonesia University (1) · Stanford University (1)
Often tested with
Tested in the same studies.
Zolpidem (2) · Buprenorphine, Naloxone Drug Combination (1) · Ethanol (1) · Famotidine (1) · Fluconazole (1) · Zopiclone (1) · Rifampin (1) · Itraconazole (1)
Studies
Open first, then newest update. How each study uses lemborexant is read from its arms, and is right about nine times in ten.
Testing it · 51
- Lemborexant on Perioperative Sleep Quality in Patients Undergoing Thoracoscopic SurgeryNot yet recruitingPhase 2Beijing Tiantan HospitalNCT07811401Written as Lemborexant 5 mg
- Lemborexant for Sleep and Delirium Prevention in Elderly ICU PatientsRecruitingPhase 4Mahidol UniversityNCT07407400Written as Lemborexant
- How Well and Safely Does Lemborexant Work for People Who Wake up at Night to Urinate (LENS)Not yet recruitingPhase 4University of AlbertaNCT07840638Written as Lemborexant tablets
- Lemborexant for Cannabis Use DisorderNot yet recruitingPhase 1/2University of CalgaryNCT07802990Written as Lemborexant 10mg
- A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.RecruitingPhase 2Woolcock Institute of Medical ResearchNCT06823752Written as Lemborexant 10 MG
- Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty SleepingRecruitingPhase 2Flinders UniversityNCT06928766Written as Lemborexant 10mg
- DORA and LP in Alzheimer's Disease BiomarkersRecruitingPhase 2University of MinnesotaNCT06274528Written as Lemborexant 10 mg
- Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder SubjectsRecruitingPhase 2Virginia Commonwealth UniversityNCT06981195Written as Lemborexant 10 MG
- The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal ThresholdNot yet recruitingPhase 1/2Chulalongkorn UniversityNCT07683442Written as Lemborexant 5 MG [Dayvigo] Period 1
- Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's DiseaseNot yet recruitingPhase 4YangPanNCT07384429Written as Lemborexant
- Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery PatientsNot yet recruitingPhase 2University of British ColumbiaNCT06648681Written as Lemborexant 5 mg
- Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic InsomniaRecruitingNot applicableLaval UniversityNCT06779149Written as Lemborexant
- Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 TrialRecruitingPhase 4Nova Scotia Health AuthorityNCT06093126Written as Lemborexant 5 MG
- Lemborexant Treatment of Insomnia Linked to EpilepsyRecruitingPhase 3University of ManitobaNCT06262594Written as Lemborexant
- Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift WorkersRecruitingPhase 3Phramongkutklao College of Medicine and HospitalNCT06496282Written as Lemborexant
- Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)TerminatedPhase 2Unity Health TorontoNCT06843187Written as Lemborexant
- The Effects of Lemborexant on the Ability to Sleep During DaytimeTerminatedPhase 2Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de MontrealNCT06231641Written as Lemborexant 5 MG [Dayvigo]
- Lemborexant Augmentation of Naltrexone for Alcohol Craving and SleepCompletedPhase 3Baylor College of MedicineNCT05458609Written as Lemborexant 10 mg
- Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep ProblemsCompletedPhase 2Indonesia UniversityNCT07480096Written as Lemborexant
Codes
What other systems call lemborexant · ClinicalTrials.gg INT001158
- MeSH (NLM) C000634104lemborexantConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0K5743G68XLEMBOREXANTConfirmed FDA, NLM, Wikidata
- RxNorm 2272403One source FDA
- Wikidata Q20707990lemborexantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166424LemborexantOne source FDA
- DrugBank DB11951One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000634104 | lemborexant | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0K5743G68X | LEMBOREXANT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2272403 | — | One source FDA |
| Wikidata | Q20707990 | lemborexant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166424 | Lemborexant | One source FDA |
| DrugBank | DB11951 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.